Evidence map›Paper›PMID 15249662›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Development of a cancer DNA phenotype prior to tumor formation.

Donald C Malins, Katie M Anderson, Naomi K Gilman, Virginia M Green, Edward A Barker, Karl Erik Hellström

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Administration of cyclophosphamide changes the immune profile of tumor-bearing mice.Journal of immunotherapy (Hagerstown, Md. : 1997) · 2010
    Article
  17. Correlated alterations in prostate basal cell layer and basement membrane.International journal of biological sciences · 2009
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Donald C MalinsBiochemical Oncology Program, Pacific Northwest Research Institute, 720 Broadway, Seattle, WA 98122, USA. dmalins@pnri.org
Katie M Anderson
Naomi K Gilman
Virginia M Green
Edward A Barker
Karl Erik Hellström
Molecular Oncology (United States) · US

Funding

DNA DAMAGE IN MOUSE TUMORS EVAL BY IR SPECTROSCOPYR01CA079479 · NCI · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI MALINS, DONALD C · 1999 to 2002
$886k
NCI NIH HHS CA79479NCI NIH HHS R01 CA079479
6 · The paper itself

Abstract

Using the carcinogen 3-methylcholanthrene (MCA), we demonstrate with Fourier transform-infrared spectroscopy that a cancer DNA phenotype is produced well in advance of palpable tumors. We further demonstrate that the administration of cyclophosphamide markedly inhibits the development of the cancer phenotype and concomitantly delays tumor formation. MCA, injected into the hind legs of mice, produced a variety of significant structural changes in the nucleotide bases and phosphodiester-deoxyribose backbone, as reflected in a substantial (34%) difference between the mean DNA spectra of the control and the MCA-injected mice. Strikingly, 57 days before the mean appearance of tumors, we could not distinguish the DNA structure of the histologically normal tissues of the MCA-injected mice from the DNA structure of the tumor tissues. This finding indicates the early development of a cancer phenotype. Confirmatory evidence was obtained when tissues from a group of mice injected with both MCA and cyclophosphamide did not manifest the cancer phenotype, and their mean DNA structure closely resembled that of the control mice. Accordingly, we propose that the cancer DNA phenotype, as evinced by Fourier transform-infrared spectroscopy, is a promising early indicator of tumor formation, and we postulate that agents capable of inhibiting this phenotype may delay or prevent carcinogenesis.

Indexed as

PhenotypeAnimalsAntineoplastic Agents, AlkylatingCyclophosphamideDNAFemaleMethylcholanthreneMiceMice, Inbred BALB CMuscle, SkeletalNeoplasmsSpectroscopy, Fourier Transform InfraredAntineoplastic Agents, AlkylatingCyclophosphamideDNAMethylcholanthrene

Identifiers

PMID15249662
PMCPMC490001
OpenAlexW1661741909

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.